Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01040039 · ClinicalTrials.gov registry record

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

A clinical trial, sponsored by Rockefeller University.

Terminated
Registry status
20
Enrollment target

NCT01040039: Clinical Trial study, sponsored by Rockefeller University.

NCT01040039 is a clinical trial that was terminated before completion, run by Rockefeller University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01040039 was terminated before completion, sponsored by Rockefeller University.

TERMINATED
Registry status
20 participants
Enrollment target

Study Summary

This pilot study aims to study gut B cells in HCV+HIV+, HCV+HIV-, HCV-HIV+, and HCV-HIV- volunteers. Volunteers will undergo a screening blood draw and flexible sigmoidoscopy with biopsy.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2009-11
Est. Completion 2011-09
Rockefeller University

117 total trials

Why NCT01040039 stopped before completion

NCT01040039 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01040039 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01040039 about?

NCT01040039 is a clinical study titled "Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV". This pilot study aims to study gut B cells in HCV+HIV+, HCV+HIV-, HCV-HIV+, and HCV-HIV- volunteers. Volunteers will undergo a screening blood draw and flexible sigmoidoscopy with biopsy.

What is the current status of trial NCT01040039?

This trial is currently terminated. The enrollment target is 20 participants. The study started on 2009-11. Estimated completion is 2011-09.

Who is sponsoring clinical trial NCT01040039?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01040039, the US trial registry maintained by the National Library of Medicine. NCT01040039 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.